Global COVID-19 Testing Market to 2026 - Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing - ResearchAndMarkets.com

The "COVID-19 Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for COVID-19 Testing estimated at US$19.3 Billion in the year 2020, is projected to decline to revised size of US$10.4 Billion by 2026, declining at a CAGR of -11.8% over the analysis period.

RT-PCR Assay Kits, one of the segments analyzed in the report, is projected to record a -12.4% CAGR and shrink to US$5.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunoassay Test Strips/Cassettes segment is readjusted to a revised -10.3% CAGR for the next 7-year period.

RT-PCR is the most popular diagnostic technique in the market as it is reliable, sensitive and relatively quick, offering results within 3-4 hours. It is designed to detect the presence of viral RNA in patient samples by capturing as well as amplifying specific segments of the generic material of the virus, mainly the Spike protein, envelop or N protein. The immunoassay segment is growing rapidly, due to rising acceptance of rapid immunoassay tests. The market is likely to receive a notable contribution from the point-of-care (POC) segment. These tests are easy to access and eliminate the requirement of skilled professionals.

The U.S. Market is Estimated at $5.2 Billion in 2021, While China is Forecast to Dwindle to $246.2 Million by 2026

The COVID-19 Testing market in the U.S. is estimated at US$5.2 Billion in the year 2021. China, the world's second largest economy, is forecast to shrink to US$246.2 Million by the year 2026 trailing a negative CAGR of -30.1% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to record negative CAGR of -10.7% and -9.8% respectively over the analysis period.

Select Competitors (Total 547 Featured):

• 3D Biomedicine Science & Technology Co., Limited
• Abbott Laboratories
• Advaite, Inc.
• AlphaBiolabs Ltd
• BGI Genomics Co. Ltd.
• BioFire Diagnostics LLC
• BioMedomics Inc
• Bioscience (Tianjin) Diagnostic Technology Co., LTD
• Cellex
• Cepheid Inc.
• Chembio Diagnostic Systems, Inc.
• Co-Diagnostics Inc.
• Dynamiker Biotechnology (Tianjin) Co., Ltd.
• GenMark Diagnostics, Inc.
• Hologic, Inc
• Innovita Biological Technology Co., Ltd
• Mayo Clinic Laboratories

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Types of COVID-19 Testing
• Different Types of Coronavirus Tests
• Performance Analysis of COVID-19 Tests
• Rapid Tests Help in Controlling the Virus
• How Will COVID-19 Testing Change in 2021
• Massive Testing to Become a Way of Life
• COVID-19 to Drive Hospital and Diagnostic Lab Revenues in 2021
• Global Market Prospects and Outlook
• COVID-19 Testing Witnesses Staggering Growth Due to Rising Incidence of Corona Virus
• Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS AND ISSUES

• Rising Incidence of Coronavirus Cases Drive the Need for Testing
• Pandemic Gives Rise to Innovative Partnership Models
• Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics
• Increasing Point-of-Care Molecular Testing
• Accelerated Development and Faster Adoption of New Technologies
• Expansion of Manufacturing Capacity in Asia and Shift of Supply
• Positioning for the Future
• Some Innovative Testing Methods for COVID-19:
• CRISPR
• Bioluminescence Testing
• Lab-on-chip Testing
• LAMpore Kits
• Covid-19 NudgeBox Test by DNANudge
• High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market
• Rapid Test Kits Market for COVID-19 to Exhibit Exponential Growth
• Select Approved COVID-19 Rapid Tests
• Point-of-Care Tests Witness Rapid Growth
• High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
• Mass Community Testing Holds the Key for Effective COVID-19 Management
• The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms
• CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
• Innovations and Approvals
• Portable PoC Test with a Smartphone Reader
• Saliva Test
• FDA Approves First Molecular Test for Asymptomatic Patients
• New Molecular Test N1-STOP-LAMP
• LumiraDx SARS-CoV-2 Antigen Test
• Integration of Sophisticated Technology to Drive Market Growth
• Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing
• In-home Testing for Covid-19
• FDA Authorizes Home Collection Option for LabCorp's COVID-19 Diagnostic Test
• A Rapid Genomics Strategy to Trace Coronavirus
• The pioneering of Rapid Genomics
• Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic
• Digital Technologies Gaining Adoption Amid COVID-19
• List of COVID-19 Contact Tracing Apps
• Amazon Offers FDA-Approved COVID-19 Test
• Alliance of BMGF and Life Science Companies Pledge to Improve Access
• Ensuring the Perfect Mix of COVID-19 Testing
• Testing Rate & Average Turnaround Time to Results as Key Metrics
• Growing Significance of Pooled Testing
• Participation of Public & Private Sector
• Avoiding Supply Mismatch

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/olhrxz

View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005446/en/